Abstract:Hyperkeratotic capillary-venous malformations (HCCVMs) are rare cutaneous lesions that occur in a small subgroup of patients with cerebral capillary malformation (CCM). CCMs cause neurological problems that range from headaches to life-threatening intracranial bleeding. CCMs and HCCVMs have a similar histopathological appearance of dilated capillary-venous channels. Genetic linkage of inherited CCMs has been established to three chromosomal loci, 3q25. 2-27, 7p13-15 and 7q21-22. The first mutations were identi… Show more
“…No gross lesions were observed on cursory examination of the other internal organs. Because cutaneous vascular lesions have been reported in some human CCM patients, 3 we flayed several Ccm1 ϩ/Ϫ Trp53 Ϫ/Ϫ animals and examined the underside of the skin. No vascular lesions were visible.…”
Section: Identification Of Vascular Lesions In Ccm1mentioning
confidence: 99%
“…Cavernous malformations can form in any part of the central nervous system, and some patients with CCM also have cutaneous vascular malformations. 3 Hemorrhaging of the vessels in a cavernous malformation can result in headaches, seizures, and stroke, that are sometimes lethal.…”
Cerebral cavernous malformations (CCM) consist of clusters of abnormally dilated blood vessels. Hemorrhaging of these lesions can cause seizures and lethal stroke. Three loci are associated with autosomal dominant CCM, and the causative genes have been identified for CCM1 and CCM2. We have generated mice with a targeted mutation of the Ccm1 gene, but an initial survey of 20 heterozygous mice failed to detect any cavernous malformations. To test the hypothesis that growth of cavernous malformations depends on somatic loss of heterozygosity at the Ccm1 locus, we bred animals that were heterozygous for the Ccm1 mutation and homozygous for loss of the tumor suppressor Trp53 (p53), which has been shown to increase the rate of somatic mutation. We observed vascular lesions in the brains of 55% of the doublemutant animals but none in littermates with other genotypes. Although the genetic evidence suggested somatic mutation of the wild-type Ccm1 allele, we were unable to demonstrate loss of heterozygosity by molecular methods. An alternative explanation is that p53 plays a direct role in formation of the vascular malformations. The striking similarity of the human and mouse lesions indicates that the Ccm1
“…No gross lesions were observed on cursory examination of the other internal organs. Because cutaneous vascular lesions have been reported in some human CCM patients, 3 we flayed several Ccm1 ϩ/Ϫ Trp53 Ϫ/Ϫ animals and examined the underside of the skin. No vascular lesions were visible.…”
Section: Identification Of Vascular Lesions In Ccm1mentioning
confidence: 99%
“…Cavernous malformations can form in any part of the central nervous system, and some patients with CCM also have cutaneous vascular malformations. 3 Hemorrhaging of the vessels in a cavernous malformation can result in headaches, seizures, and stroke, that are sometimes lethal.…”
Cerebral cavernous malformations (CCM) consist of clusters of abnormally dilated blood vessels. Hemorrhaging of these lesions can cause seizures and lethal stroke. Three loci are associated with autosomal dominant CCM, and the causative genes have been identified for CCM1 and CCM2. We have generated mice with a targeted mutation of the Ccm1 gene, but an initial survey of 20 heterozygous mice failed to detect any cavernous malformations. To test the hypothesis that growth of cavernous malformations depends on somatic loss of heterozygosity at the Ccm1 locus, we bred animals that were heterozygous for the Ccm1 mutation and homozygous for loss of the tumor suppressor Trp53 (p53), which has been shown to increase the rate of somatic mutation. We observed vascular lesions in the brains of 55% of the doublemutant animals but none in littermates with other genotypes. Although the genetic evidence suggested somatic mutation of the wild-type Ccm1 allele, we were unable to demonstrate loss of heterozygosity by molecular methods. An alternative explanation is that p53 plays a direct role in formation of the vascular malformations. The striking similarity of the human and mouse lesions indicates that the Ccm1
“…Familial CCMs are inherited in an autosomal dominant pattern, constitute up to 50% of CCM cases, and have been found to be associated with loss-of-function mutations in 3 genes, KRIT1 (also known as CCM1) (1)(2)(3), CCM2 (MALCAVERNIN, OSM) (4,5), and PDCD10 (CCM3) (6,7). Genetic studies in zebrafish have demonstrated that loss of ccm1, ccm2, or the transmembrane receptor heart of glass (heg) results in embryonic cardiovascular phenotypes characterized by a large, thin-walled heart and defective branchial arch artery development that prevents blood circulation (8)(9)(10).…”
“…This dearth of molecular details is striking, considering the growing list of germline mutations in genes causing specific inherited syndromes involving vascular malformations, including hereditary hemorrhagic telangiectasia (4,5), cutaneous venous malformations (6), cerebral cavernous malformations (7,8), and hyperkeratotic cutaneous capillary-venous malformation (9). Are we able to investigate hemangioma in a similar manner?…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.